Serranator Study
Brief description of study
This is a single arm, multi-center device registry study capturing de-identified data on a minimum of 500 subjects with peripheral artery disease (PAD). The objective of this registry is to collect observational data under local standard of care and evaluate safety and performance of the SerranatorĀ® in treatment of peripheral artery disease (PAD), or dysfunctional native or synthetic arteriovenous dialysis fistulae in a real-world scenario.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
TBD
Find a site
,
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study
Select a study center that’s convenient for you, and get in touch with the study team.
Contact a study centerPlease choose between Voice or SMS based delivery of verification code
or